Buy Opana ER 30mg in UK Online

Opana ER 30mg is an extended-release (ER) formulation of oxymorphone hydrochloride, a strong opioid analgesic developed for the management of severe, persistent pain requiring continuous, around-the-clock opioid treatment. The extended-release formulation releases the medicine gradually over about 12 hours and is intended only for patients whose pain cannot be adequately controlled with other treatment options. (FDA Access Data)

For people in the United Kingdom, it is important to know that Opana ER is not licensed or routinely prescribed in the UK. In addition, the original Opana ER brand was discontinued in the United States following an FDA request related to public health concerns, although generic extended-release oxymorphone products may still exist in some countries. (Drugs.com)

What Is Opana ER 30mg?

Each extended-release tablet contains:

• Active ingredient: Oxymorphone hydrochloride
• Strength: 30 mg
• Medicine class: Strong opioid (opioid analgesic)
• Formulation: Extended-release (modified-release) tablet

Oxymorphone is a semi-synthetic opioid that reduces pain by acting on opioid receptors in the brain and spinal cord.

How Does It Work?

Oxymorphone primarily activates mu-opioid receptors, which decreases the transmission of pain signals and changes how the brain perceives pain.

This may help:

• Reduce severe chronic pain
• Improve comfort and physical function in some patients
• Provide continuous pain relief when taken as prescribed

Because it also depresses the central nervous system, it can cause drowsiness and slow breathing.

Medical Uses

Where available, Opana ER has been prescribed for adults with pain that:

• Is severe and persistent
• Requires around-the-clock opioid treatment
• Has not responded adequately to non-opioid medicines or immediate-release opioids
• Is expected to require long-term treatment

It is not appropriate for:

• Mild pain
• Short-term pain
• Occasional pain
• Breakthrough pain
• “As-needed” pain relief

(FDA Access Data)

Availability in the UK

Opana ER 30 mg is not licensed or routinely prescribed in the United Kingdom. When long-acting opioid therapy is necessary, UK healthcare professionals generally prescribe medicines licensed for UK use, such as prolonged-release morphine or oxycodone, depending on the patient’s clinical needs. (nhs.uk)

Important Safety Information

Extended-release opioid tablets should always be:

• Taken exactly as prescribed.
• Swallowed whole with water.
• Never crushed, chewed, split, or dissolved.

Damaging an extended-release tablet can release the full dose immediately, greatly increasing the risk of life-threatening overdose. (FDA Access Data)

Common Side Effects

Like other opioid medicines, oxymorphone may cause:

• Constipation
• Nausea
• Vomiting
• Drowsiness
• Dizziness
• Dry mouth
• Headache
• Sweating

Constipation is particularly common and may require preventive treatment.

Serious Side Effects

Seek emergency medical attention immediately if someone develops:

• Difficulty breathing
• Slow or shallow breathing
• Extreme sleepiness or inability to wake
• Blue lips or fingertips
• Loss of consciousness
• Severe allergic reaction

These symptoms may indicate an opioid overdose or another medical emergency. (MedlinePlus)

Dependence, Tolerance, and Addiction

Like all strong opioids, oxymorphone carries important risks of:

• Physical dependence
• Tolerance
• Opioid use disorder (addiction)

These risks increase with higher doses and longer treatment. If long-term opioid therapy needs to be stopped, it is usually reduced gradually under medical supervision to lower the risk of withdrawal symptoms. (FDA Access Data)

Drug Interactions

Oxymorphone can interact with:

• Other opioid medicines
• Benzodiazepines
• Sleeping tablets
• Alcohol
• Muscle relaxants
• Other medicines that cause drowsiness

These combinations can significantly increase the risk of excessive sedation, dangerously slowed breathing, coma, and death.

Alcohol

Alcohol should be avoided while taking extended-release opioids because it can increase the risk of:

• Severe drowsiness
• Respiratory depression
• Accidental overdose

(FDA Access Data)

Driving

Do not drive or operate machinery if oxymorphone causes:

• Sleepiness
• Dizziness
• Poor concentration
• Slowed reaction times

Driving while impaired by opioids is unsafe and may be unlawful.

Pregnancy and Breastfeeding

Strong opioids are generally used during pregnancy only when the expected benefits outweigh the potential risks. Prolonged opioid use during pregnancy may lead to neonatal opioid withdrawal syndrome after birth. If you are pregnant, planning pregnancy, or breastfeeding, discuss treatment options with your healthcare professional before using any opioid medicine.

Storage

Store opioid medicines:

• In their original packaging.
• At room temperature.
• Away from moisture and heat.
• Securely and out of the sight and reach of children.

Unused tablets should be returned to a pharmacy for safe disposal.

Frequently Asked Questions

Is Opana ER 30 mg available in the UK?

No. Opana ER is not licensed or routinely prescribed in the UK. (Drugs.com)

Can Opana ER be used for sudden pain?

No. It is intended only for continuous management of severe, persistent pain, not occasional or breakthrough pain.

Can the tablet be crushed or split?

No. Extended-release tablets must always be swallowed whole because crushing, chewing, or splitting them can rapidly release the full dose and substantially increase the risk of overdose. (FDA Access Data)

Is the Opana ER brand still available?

The original Opana ER brand has been discontinued in the United States, although generic oxymorphone extended-release tablets may still be available in some markets. (Drugs.com)

Key Takeaways

Opana ER 30 mg is an extended-release oxymorphone tablet that was developed for the treatment of severe, persistent pain requiring continuous opioid therapy. It is not licensed or routinely prescribed in the UK, and the original Opana ER brand has been discontinued in the United States. Like all strong opioids, it carries significant risks, including constipation, drowsiness, respiratory depression, dependence, addiction, and overdose. It should only be used under the supervision of a qualified healthcare professional, exactly as prescribed, and the tablets should always be swallowed whole.